StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Other Products (Segment Note 2 Aggregate) by Quarter

Other Products (Segment Note 2 Aggregate) — Worldwide product sales ($M) ($M)

QuarterlyAnnual

Amgen Other Products (Segment Note 2 Aggregate): $1,697M in Q2 2026, up 23.0% from a year earlier.

Latest, Q2 2026
1,697
Period ended Jun 30, 2026
Change on a year earlier
+23.0%
1,380 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
33
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Note 2 Segment Reporting & MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Products (Segment Note 2 Aggregate) — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,697+23.0%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20261,528+3.6%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 20252,073+32.2%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20251,853+36.0%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20251,380+4.1%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 20251,475+7.4%Form 10-Q (filed 2026-05-01) ↗
Q4 2024Dec 31, 20241,568+14.0%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20241,363+35.8%Form 10-Q (filed 2025-11-05) ↗
Q2 2024Jun 30, 20241,326+15.9%Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 20241,373+17.2%Form 10-Q (filed 2025-05-02) ↗
Q4 2023Dec 31, 20231,376+8,500.0%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 20231,004-40.0%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 20231,144-33.0%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 20231,172-29.1%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 202216-98.9%Form 10-K (filed 2025-02-14) ↗
Q3 2022Sep 30, 20221,673+15.1%Form 10-Q (filed 2023-10-31) ↗

Breakdown

What makes up other Products (Segment Note 2 Aggregate)

Cite this data

StockData. (2026). Amgen Other Products (Segment Note 2 Aggregate) ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-other-ww

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.